Sunitinib in refractory adrenocortical carcinoma: A phase II, single-arm, open-label trial - Kroiss, M; Quinkler, M; Johanssen, S (J Clin Endocrinol Metab, 2012)
doi:jc.2012-1419 [pii] DOI 10.1210/jc.2012-1419